A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network
A hallmark of diseases of protein conformation and aging is the appearance of protein aggregates associated with cellular toxicity. We posit that the functional properties of the proteostasis network (PN) protect the proteome from misfolding and combat the proteotoxic events leading to cellular pathology. In this study, we have identified new components of the proteostasis network that can suppress aggregation and proteotoxicity, by performing RNA interference (RNAi) genetic screens for multiple unrelated conformationally challenged cytoplasmic proteins expressed in Caenorhabditis elegans. We identified 88 suppressors of polyglutamine (polyQ) aggregation, of which 63 modifiers also suppressed aggregation of mutant SOD1G93A. Of these, only 23 gene-modifiers suppressed aggregation and restored animal motility, revealing that aggregation and toxicity can be genetically uncoupled. Nine of these modifiers were shown to be effective in restoring the folding and function of multiple endogenous temperature-sensitive (TS) mutant proteins, of which five improved folding in a HSF-1–dependent manner, by inducing cytoplasmic chaperones. This triage screening strategy also identified a novel set of PN regulatory components that, by altering metabolic and RNA processing functions, establish alternate cellular environments not generally dependent on stress response activation and that are broadly protective against misfolded and aggregation-prone proteins.
Vyšlo v časopise:
A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network. PLoS Genet 7(12): e32767. doi:10.1371/journal.pgen.1002438
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002438
Souhrn
A hallmark of diseases of protein conformation and aging is the appearance of protein aggregates associated with cellular toxicity. We posit that the functional properties of the proteostasis network (PN) protect the proteome from misfolding and combat the proteotoxic events leading to cellular pathology. In this study, we have identified new components of the proteostasis network that can suppress aggregation and proteotoxicity, by performing RNA interference (RNAi) genetic screens for multiple unrelated conformationally challenged cytoplasmic proteins expressed in Caenorhabditis elegans. We identified 88 suppressors of polyglutamine (polyQ) aggregation, of which 63 modifiers also suppressed aggregation of mutant SOD1G93A. Of these, only 23 gene-modifiers suppressed aggregation and restored animal motility, revealing that aggregation and toxicity can be genetically uncoupled. Nine of these modifiers were shown to be effective in restoring the folding and function of multiple endogenous temperature-sensitive (TS) mutant proteins, of which five improved folding in a HSF-1–dependent manner, by inducing cytoplasmic chaperones. This triage screening strategy also identified a novel set of PN regulatory components that, by altering metabolic and RNA processing functions, establish alternate cellular environments not generally dependent on stress response activation and that are broadly protective against misfolded and aggregation-prone proteins.
Zdroje
1. TaylorJPHardyJFischbeckKH 2002 Toxic proteins in neurodegenerative disease. Science 296 1991 1995
2. RueggMAGlassDJ 2011 Molecular mechanisms and treatment options for muscle wasting diseases. Annual review of pharmacology and toxicology 51 373 395
3. SotoC 2003 Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4 49 60
4. SotoCEstradaLD 2008 Protein misfolding and neurodegeneration. Arch Neurol 65 184 189
5. StefaniM 2004 Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta 1739 5 25
6. BalchWEMorimotoRIDillinAKellyJW 2008 Adapting proteostasis for disease intervention. Science 319 916 919
7. MorimotoRI 2008 Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22 1427 1438
8. MorimotoRICuervoAM 2009 Protein homeostasis and aging: taking care of proteins from the cradle to the grave. The journals of gerontology Series A, Biological sciences and medical sciences 64 167 170
9. OlzschaHSchermannSMWoernerACPinkertSHechtMH 2011 Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144 67 78
10. GidalevitzTBen-ZviAHoKHBrignullHRMorimotoRI 2006 Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311 1471 1474
11. GidalevitzTKikisEAMorimotoRI 2010 A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol 20 23 32
12. GidalevitzTKrupinskiTGarciaSMorimotoRI 2009 Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet 5 e1000399 doi:10.1371/journal.pgen.1000399
13. RossCAPoirierMA 2005 Opinion: What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 6 891 898
14. TreuschSCyrDMLindquistS 2009 Amyloid deposits: protection against toxic protein species? Cell cycle 8 1668 1674
15. ArrasateMMitraSSchweitzerESSegalMRFinkbeinerS 2004 Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 805 810
16. GutekunstCALiSHYiHMulroyJSKuemmerleS 1999 Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19 2522 2534
17. KirkitadzeMDBitanGTeplowDB 2002 Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res 69 567 577
18. Van RaamsdonkJMMurphyZSlowEJLeavittBRHaydenMR 2005 Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet 14 3823 3835
19. ZoghbiHYOrrHT 1999 Polyglutamine diseases: protein cleavage and aggregation. Current opinion in neurobiology 9 566 570
20. GlabeCGKayedR 2006 Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66 S74 78
21. van HamTJBreitlingRSwertzMANollenEA 2009 Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO molecular medicine 1 360 370
22. PowersETMorimotoRIDillinAKellyJWBalchWE 2009 Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78 959 991
23. BrignullHRMooreFETangSJMorimotoRI 2006 Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci 26 7597 7606
24. FaberPWAlterJRMacDonaldMEHartAC 1999 Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A 96 179 184
25. FeanyMBBenderWW 2000 A Drosophila model of Parkinson's disease. Nature 404 394 398
26. MorleyJFBrignullHRWeyersJJMorimotoRI 2002 The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99 10417 10422
27. OuteiroTFMuchowskiPJ 2004 Molecular genetics approaches in yeast to study amyloid diseases. J Mol Neurosci 23 49 60
28. Van RaamsdonkJMWarbySCHaydenMR 2007 Selective degeneration in YAC mouse models of Huntington disease. Brain Res Bull 72 124 131
29. WarrickJMPaulsonHLGray-BoardGLBuiQTFischbeckKH 1998 Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93 939 949
30. WatsonMRLagowRDXuKZhangBBoniniNM 2008 A Drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem 238 24972 24981
31. KraemerBCZhangBLeverenzJBThomasJHTrojanowskiJQ 2003 Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proceedings of the National Academy of Sciences of the United States of America 100 9980 9985
32. BilenJBoniniNM 2007 Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 3 e177 doi:10.1371/journal.pgen.0030177
33. Kazemi-EsfarjaniPBenzerS 2000 Genetic suppression of polyglutamine toxicity in Drosophila. Science 287 1837 1840
34. KraemerBCBurgessJKChenJHThomasJHSchellenbergGD 2006 Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum Mol Genet 15 1483 1496
35. NollenEAGarciaSMvan HaaftenGKimSChavezA 2004 Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A 101 6403 6408
36. van HamTJThijssenKLBreitlingRHofstraRMPlasterkRH 2008 C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 4 e1000027 doi:10.1371/journal.pgen.1000027
37. WangJFarrGWHallDHLiFFurtakK 2009 An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet 5 e1000350 doi:10.1371/journal.pgen.1000350
38. WillinghamSOuteiroTFDeVitMJLindquistSLMuchowskiPJ 2003 Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302 1769 1772
39. ZhangSBinariRZhouRPerrimonN 2010 A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184 1165 1179
40. KamathRSAhringerJ 2003 Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30 313 321
41. KamathRSFraserAGDongYPoulinGDurbinR 2003 Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421 231 237
42. Ben-ZviAMillerEAMorimotoRI 2009 Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A 106 14914 14919
43. GarciaSMCasanuevaMOSilvaMCAmaralMDMorimotoRI 2007 Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells. Genes Dev 21 3006 3016
44. Gengyo-AndoKKagawaH 1991 Single charge change on the helical surface of the paramyosin rod dramatically disrupts thick filament assembly in Caenorhabditis elegans. Journal of molecular biology 219 429 441
45. DillinAHsuALArantes-OliveiraNLehrer-GraiwerJHsinH 2002 Rates of behavior and aging specified by mitochondrial function during development. Science 298 2398 2401
46. LeeSSLeeRYFraserAGKamathRSAhringerJ 2003 A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet 33 40 48
47. ReaSLVenturaNJohnsonTE 2007 Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol 5 e259 doi:10.1371/journal.pbio.0050259
48. DurieuxJWolffSDillinA 2011 The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144 79 91
49. HansenMTaubertSCrawfordDLibinaNLeeSJ 2007 Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 6 95 110
50. TavernarakisN 2008 Ageing and the regulation of protein synthesis: a balancing act? Trends Cell Biol 18 228 235
51. MattsonMP 2008 Dietary factors, hormesis and health. Ageing Res Rev 7 43 48
52. MuchowskiPJSchaffarGSittlerAWankerEEHayer-HartlMK 2000 Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A 97 7841 7846
53. SakahiraHBreuerPHayer-HartlMKHartlFU 2002 Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci U S A 99 Suppl 4 16412 16418
54. WangXVenableJLaPointePHuttDMKoulovAV 2006 Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127 803 815
55. CummingsCJSunYOpalPAntalffyBMestrilR 2001 Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet 10 1511 1518
56. FreemanBCToftDOMorimotoRI 1996 Molecular chaperone machines: chaperone activities of the cyclophilin Cyp-40 and the steroid aporeceptor-associated protein p23. Science 274 1718 1720
57. EvansCGWisenSGestwickiJE 2006 Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1–42) aggregation in vitro. J Biol Chem 281 33182 33191
58. WackerJLZareieMHFongHSarikayaMMuchowskiPJ 2004 Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat Struct Mol Biol 11 1215 1222
59. BallingerCAConnellPWuYHuZThompsonLJ 1999 Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19 4535 4545
60. NollenEABrunstingJFSongJKampingaHHMorimotoRI 2000 Bag1 functions in vivo as a negative regulator of Hsp70 chaperone activity. Mol Cell Biol 20 1083 1088
61. MuchowskiPJNingKD'Souza-SchoreyCFieldsS 2002 Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment. Proc Natl Acad Sci U S A 99 727 732
62. LegleiterJMitchellELotzGPSappENgC 2010 Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo. The Journal of biological chemistry 285 14777 14790
63. TakahashiYOkamotoYPopielHAFujikakeNTodaT 2007 Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopy. J Biol Chem 282 24039 24048
64. ThakurAKJayaramanMMishraRThakurMChellgrenVM 2009 Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol 16 380 389
65. MillerJArrasateMShabyBAMitraSMasliahE 2010 Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. The Journal of neuroscience: the official journal of the Society for Neuroscience 30 10541 10550
66. CohenEBieschkeJPerciavalleRMKellyJWDillinA 2006 Opposing activities protect against age-onset proteotoxicity. Science 313 1604 1610
67. KarpinarDPBalijaMBKuglerSOpazoFRezaei-GhalehN 2009 Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. The EMBO journal 28 3256 3268
68. SaudouFFinkbeinerSDevysDGreenbergME 1998 Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95 55 66
69. LamitinaTHuangCGStrangeK 2006 Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression. Proc Natl Acad Sci U S A 103 12173 12178
70. HamiltonBDongYShindoMLiuWOdellI 2005 A systematic RNAi screen for longevity genes in C. elegans. Genes Dev 19 1544 1555
71. GiorginiFGuidettiPNguyenQBennettSCMuchowskiPJ 2005 A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet 37 526 531
72. GottschalkAAlmedomRBSchedletzkyTAndersonSDYatesJR3rd 2005 Identification and characterization of novel nicotinic receptor-associated proteins in Caenorhabditis elegans. EMBO J 24 2566 2578
73. SzewczykNJHartmanJJBarmadaSJJacobsonLA 2000 Genetic defects in acetylcholine signalling promote protein degradation in muscle cells of Caenorhabditis elegans. J Cell Sci 113 Pt 11 2003 2010
74. BrennerS 1974 The genetics of Caenorhabditis elegans. Genetics 77 71 94
75. PhairRDMisteliT 2000 High mobility of proteins in the mammalian cell nucleus. Nature 404 604 609
76. KlopfensteinDRValeRD 2004 The lipid binding pleckstrin homology domain in UNC-104 kinesin is necessary for synaptic vesicle transport in Caenorhabditis elegans. Mol Biol Cell 15 3729 3739
77. Teixeira-CastroAAilionMJallesABrignullHRVilacaJL 2011 Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways. Human molecular genetics 20 2996 3009
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 12
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
Najčítanejšie v tomto čísle
- Targeted Proteolysis of Plectin Isoform 1a Accounts for Hemidesmosome Dysfunction in Mice Mimicking the Dominant Skin Blistering Disease EBS-Ogna
- An Assessment of the Individual and Collective Effects of Variants on Height Using Twins and a Developmentally Informative Study Design
- Genomes Reveal Transition of Bacteria from Aquatic to Terrestrial Environments
- A Complex Genomic Rearrangement Involving the Locus Causes Dermal Hyperpigmentation in the Chicken